Paclitaxel Nanoparticles to Treat Late Stage Peritoneal Mesothelioma

A group of graduate students and postdoctoral fellows at Boston Universityare trying to find a better treatment for late-stage peritoneal mesothelioma. The group is developing a method to deliver chemotherapy drugs directly to tumor cells withnanoparticleswhich are absorbed by the tumor cells and release the drugs. The detailedstudypublished February 4, on the BU College of Engineering site is part of a four part series detailing current research projects being performed bytheGrinstaff Group.The Grinstaff Group chose to focus on peritoneal mesothelioma because it is easier to isolate and does not metastasize like other cancers, theoretically making it easier to attack with an innovative drug delivery system, in this case – nanoparticles loaded with paclitaxel, a chemotherapy drug commonly used to treat mesothelioma.The nanoparticles are composed of squiggly …


Read More: Paclitaxel Nanoparticles to Treat Late Stage Peritoneal Mesothelioma

#Engineering, #Grinstaff, #Grinstaffgroup, #King, #Mesothelioma, #Nanoparticles, #Paclitaxel, #Professor, #School, #Study, #Universityare